Introducing drug-anti-body conjugates

from Buddies For Life · host Solid Gold Podcasts #BeHeard

Dr Lizanne Langenhoven details how knowing the subtype of breast cancer determines treatment, and introduces the new drug-antibody conjugates for HER2-positive breast cancer. Dr Lizanne Langenhoven is a clinical and radiation oncologist at Panorama Mediclinic and forms part of a multi-disciplinary unit of excellence in the treatment of breast cancer at the Panorama Centre for Surgical Oncology. Facebook · Twitter · Instagram · LinkedIn

Episode metadata supplied by the publisher feed · Published Oct 1, 2025

Embed this episode

Attribution link and audio player

NOW PLAYING

Introducing drug-anti-body conjugates

0:00 6:05

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Buddies For Life?

This episode is 6 minutes long.

When was this Buddies For Life episode published?

This episode was published on October 1, 2025.

Can I download this Buddies For Life episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!